Close

Arbutus Biopharma (ABUS) Announces Results from Phase II Trial of ARB-1467 for Chronic HBV Infection

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/23/2024

1. TSLA
2. SPY
3. GM
4. SPOT
5. AMZN
6. SHW
7. AAPL
8. IBM
9. MINN
10. NVDA


Go back to Arbutus Biopharma (ABUS) Announces Results from Phase II Trial of ARB-1467 for Chronic HBV Infection

Arbutus Biopharma (ABUS) to Resume Trading at 4:30 PM ET

September 29, 2016 4:05 PM EDT

Arbutus Biopharma (NASDAQ: ABUS) to Resume Trading at 4:30 PM ET

... More

Arbutus Biopharma (ABUS) trading halted with news pending

September 29, 2016 4:00 PM EDT

Arbutus Biopharma (NASDAQ: ABUS) trading halted with news pending.

... More